ResearcherHouston MethodistActive in the last 2 years
Bayan Khasawneh
Matched on ORCID iD 0000-0001-7531-1178; OpenAlex author ID A5098732652. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2025: 2 papers · 2026: 1 paper
Papers 3
- NALIRIFOX versus FOLFIRINOX: reconstructed individual patient data meta-analysis of efficacy and safety in first-line treatment of unresectable or metastatic p… Co-author DOI 10.3389/fonc.2026.1902839↗
- Correlative Analysis of Tumor-Informed Circulating Tumor DNA (ctDNA) and the Survival Outcomes of Patients with Pancreatic Adenocarcinoma. Co-author DOI 10.3390/biomedicines13051124↗
- An 81-Year-Old Geriatric Patient with Metastatic Pancreatic Cancer Demonstrating Excellent Response and Well Tolerance to NALIRIFOX: A Case Report and Literatu… Co-author DOI 10.3390/reports8020069↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Abdullah Esmail · 3 shared papers, 2025–2026 · strength 0.90
- Paper An 81-Year-Old Geriatric Patient with Metastatic Pancreatic Cancer Demonstrating Excellent Response and Well Tolerance … DOI 10.3390/reports8020069↗
- Paper NALIRIFOX versus FOLFIRINOX: reconstructed individual patient data meta-analysis of efficacy and safety in first-line t… DOI 10.3389/fonc.2026.1902839↗
- Paper Correlative Analysis of Tumor-Informed Circulating Tumor DNA (ctDNA) and the Survival Outcomes of Patients with Pancrea… DOI 10.3390/biomedicines13051124↗
- Maen Abdelrahim · 3 shared papers, 2025–2026 · strength 0.90
- Paper An 81-Year-Old Geriatric Patient with Metastatic Pancreatic Cancer Demonstrating Excellent Response and Well Tolerance … DOI 10.3390/reports8020069↗
- Paper NALIRIFOX versus FOLFIRINOX: reconstructed individual patient data meta-analysis of efficacy and safety in first-line t… DOI 10.3389/fonc.2026.1902839↗
- Paper Correlative Analysis of Tumor-Informed Circulating Tumor DNA (ctDNA) and the Survival Outcomes of Patients with Pancrea… DOI 10.3390/biomedicines13051124↗
- Yuqi Zhang · 1 shared paper, 2025 · strength 0.27
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.